{"prompt": "['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', \"12. Juniper EF, Guyatt GH, O'Byrne PM, Viveiros M. Aqueous beclomethasone dipropionate\", 'nasal spray\" regular versus \"as required\" use in the treatment of seasonal allergic rhinitis J', 'Allergy Clin Imunol. 1990:863 (3Pr1):380-6.', '13. Howie SRC. Blood sample volumes in child health research: review of safe limits. Bull World', 'Health Organ. 2011;89:46-53.', 'Property of the Sanofi Group - strictly confidential', 'Page 134', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', '17 APPENDICES', 'Property of the Sanofi Group - strictly confidential', 'Page 135', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Appendix A', 'Low, Medium, and High-dose Inhaled Corticosteroids - Children', '(6 to <12 years)', 'Total Daily Dose (mcg)', 'Inhaled Corticosteroid', 'Low', 'Medium', 'High', 'Beclometasone dipropionate (CFC)', '100-200', '>200-400', '>400', 'Beclometasone dipropionate (HFA)', '50-100', '>100-200', '>200', 'Budesonide (DPI)', '100-200', '>200-400', '>400', 'Budesonide (HFA)', '100-200', '>200-400', '>400', 'Budesonide (nebules)', '250-500', '>500-1000', '>1000', 'Ciclesonide (HFA)', '80', '>80-160', '>160', 'Flunisolide (HFA)', '160', '>160-<320', '320', 'Fluticasone propionate (DPI)', '100-200', '>200-400', '>400', 'Fluticasone propionate (HFA)', '100-200', '>200-500', '>500', 'Mometasone furoate', '110', '>220-<440', '>440', 'Triamcinolone acetonide', '400-800', '>800-1200', '>1200', 'CFC = chlorofluorocarbon propellant; DPI = dry powder inhaler; HFA = hydrofluoroalkane', 'propellant; nebules = nebulized solution', 'Source: Adapted from Global Initiative for Asthma (GINA) 2015 guidelines with the addition of', 'Budesonide HFA and Flunisolide information', 'Property of the Sanofi Group - strictly confidential', 'Page 136', 'VV-CLIN-0528583 6.0']\n\n###\n\n", "completion": "END"}